Company details

HEADCOUNT

1-24

ORG TYPE

Startup

SECTOR

Energy & Climate

WEBSITE

https://www.agrivida.com

About the company

Agrivida develops corn-based technology that produces enzymes inside the kernel, marketed under the GRAINZYME® platform for animal nutrition use cases like phytase and glucanase. Agrivida positions the work around sustainability outcomes such as improving feed efficiency and reducing waste from livestock production. Public company materials also frame Agrivida as science-led, with roots in MIT-founded research. In 2023, Novus International announced an acquisition of Agrivida focused on the INTERIUS™ technology platform for embedding feed additives inside grain.

Locations and presence

Agrivida lists offices in Woburn, Massachusetts and North Platte, Nebraska. Since the 2023 acquisition announcement, Agrivida’s work sits alongside Novus International’s global animal health and nutrition footprint.

Palpable Score

47.5

/ 100

Agrivida has positive signals on learning environment and team culture, but the public hiring surface area is thin, which makes early-career access and process fairness hard to verify. The Novus acquisition improves perceived stability, yet published early-career outcomes like conversion, promotion, or retention are not available.

Pillar 1: Early-career access

Score

6.8

/ 20

The company does not publish a public jobs board or a clear list of open roles, which makes “0–3 years” entry points hard to find and plan around.

Agrivida’s public company positioning focuses on specialist scientific work in biochemistry, plant biology, molecular biology, and nutrition, which usually maps to experienced hiring rather than graduate intake.

The company provides a “Careers” option inside the contact form, but without role scopes, required experience bands, or intake timing.

‍

Pillar 2: Hiring fairness and transparency

Score

8.2

/ 20

The company routes career interest through a general contact pathway rather than a trackable ATS flow with role-specific stages and timelines.
Agrivida does not publish role expectations like interview rounds, skills tests, or task formats for candidates, which raises uncertainty for first-time applicants.
The company has too little candidate-interview feedback publicly available to judge consistency, ghosting risk, or assessment burden.

‍

Pillar 3: Learning and support

Score

11.0

/ 20

The company has employee review feedback describing “excellent training” and full involvement of technical staff in R&D, which is a strong hands-on learning signal for juniors.
Agrivida’s small-company setup in specialist lab work can enable close exposure to senior scientists, but the public materials do not spell out onboarding plans, mentorship structure, or review cadence.
The company does not publish internship program details, early-career coaching commitments, or manager expectations that would let candidates compare support across teams.

‍

Pillar 4: Pay fairness and stability

Score

10.2

/ 20

The company has review feedback mentioning stock options and regular raises, which is a real pay-stability signal for a small biotech.
Agrivida does not publish salary ranges or benefits detail publicly, which limits pay confidence for graduates who need to compare offers and cost of living.
The company’s acquisition context may change compensation policies, but there is no public guidance on how pay and equity work for junior hires post-deal.

‍

Pillar 5: Early-career outcomes

Score

11.3

/ 20

The company has a small number of employee reviews with a high overall rating and “recommend to a friend” signal, including mentions of growth opportunities and stable management vision.
Agrivida’s acquisition by Novus International is a tangible outcome that the technology platform had strategic value, but it also introduces integration risk for role clarity and progression.
The company does not publish early-career outcomes like internship-to-offer conversion, promotion timelines, or 12–24 month retention, so results are hard to verify beyond a handful of reviews.

‍